Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Bosentan alleviates the pro-fi...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.
Bibliographic Details
Main Authors:
Leask, A
,
Xu, S
,
Renzoni, E
,
Bou-Gharios, G
,
du Bois, R
,
Abraham, D
,
Black, C
Format:
Conference item
Published:
2005
Holdings
Description
Similar Items
Staff View
Similar Items
Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
by: Shiwen, X, et al.
Published: (2006)
Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
by: S. Soldano, et al.
Published: (2011-01-01)
Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
by: Alix Naert, et al.
Published: (2013-01-01)
CTGF overexpressing mice: a model for human scleroderma
by: Sonnylal, S, et al.
Published: (2006)
Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
by: Emma Di Poi, et al.
Published: (2023-11-01)